Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Regenerative Medicine Essentials
    • World Stem Cell Summit
    • Exploring Public Policy: Regenerative Medicine and Cell Therapies
    • Congressional Briefings
    • Regenerative Medicine and Stem Cell Action Awards
    • World Stem Cell Summit – CHINA
  • Membership/Donate
    • Membership
    • Donate
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
Select Page
Clinical Trial Results Buoy Hope for Spinal Cord Injury Patients

Clinical Trial Results Buoy Hope for Spinal Cord Injury Patients

by Bernard Siegel | Mar 16, 2017 | News & Opinions, Science

The Miami Project to Cure Paralysis, at the University of Miami Miller School of Medicine,has announced the publication of its first Food and Drug Administration (FDA) approved Phase I clinical trial involving Schwann cells used to repair the damaged spinal cord. The...

Recent Posts

  • Phase I clinical trial shows promise of adipose-derived stem cells in treating lymphedema
  • HCP Busted for Selling Fake Stem Cell Therapy
  • New institute to leverage experts to advance regenerative medicine
  • Karīna Narbute’s Research in Extracellular Vesicles Earns Her Young Investigator Award
  • Retinal cell transplant clears experimental hurdle toward treating blindness
Tweets about @WSCSummit
CC Regenerative Medicine Foundation